Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
We examined the association between the disease-modifying drugs (DMDs) for multiple sclerosis (MS) and survival in a multiregion population-based study. We accessed multiple administrative health databases from 4 Canadian provinces. Persons with MS were identified and followed from the most recent o...
Gespeichert in:
Veröffentlicht in: | Neurology : neuroimmunology & neuroinflammation 2022-09, Vol.9 (5) |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!